BackRecursion Pharmaceuticals Overview

Recursion Pharmaceuticals Intangible Assets

Recursion Pharmaceuticals's intangible assets is $280M.

Get informed when a big investor buys or sells

+ Follow
Intangible Assets
$282.89M
↓ 17.12% YoYΔ $-58.43M vs prior year quarter

Peer trimmed avg / median

Loading

Recursion Pharmaceuticals Intangible Assets History

Loading

Recursion Pharmaceuticals vs. peers: Intangible Assets Comparison

Loading

Recursion Pharmaceuticals Intangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Recursion Pharmaceuticals (RXRX) FAQ

As of the most recent data (June 2026), RXRX shows a intangible assets of $280M. That compares with $340M in the prior-year period — down 17.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, RXRX's intangible assets is now $280M (was $340M) — a 17.1% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Recursion Pharmaceuticals is outperforming or lagging.

Tracking RXRX's intangible assets over time shows whether Recursion Pharmaceuticals is scaling, shrinking, or reshaping that part of the business. The current reading is $280M That compares with $340M in the prior-year period — down 17.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this intangible assets page, Stockcircle has Recursion Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect intangible assets (currently $280M) with ownership activity and broader fundamentals.

Recursion Pharmaceuticals's intangible assets is $280M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.